Search Results for “Quiz 2024 EMC D-PDM-DY-23: Dell PowerProtect Data Manager Deploy 2023 Exam Updated Vce Download 🌋 Copy URL ➥ www.pdfvce.com 🡄 open and search for ⇛ D-PDM-DY-23 ⇚ to download for free 🥇Latest D-PDM-DY-23 Test Testking” – Page 14

Monitoring recurrent angioedema: findings from the Turkish angioedea control test validation study

582.

Demir, S.⁺, Eyice-Karabacak, D., Kocatürk, E., Ünal, D., Toprak, İ. D., Korkmaz, P., Aslan, A. F., İmren, I. G., Dikicier, B., Kahveci, N., Öztop, N., Kara, R. Ö., İşsever, H., Maurer, M., Weller, K., and Gelincik, A.: Monitoring recurrent angioedema: findings from the Turkish angioedea control test validation study. Clin. Transl. Allergy 2024: 14; e12342. IF: TBD (IF 2023: 4.60)

o.582

16.	Zuberbier, T. and Maurer, M.: Urticaria: Current opinions about etiology, diagnosis and therapy. Acta Derm. Venereol. 2007: 87; 196-205. IF: 1.93

281	Finlay, A. Y.+, Kaplan, A. P., Beck, L. A., Antonova, E. N., Balp, M. M., Zazzali, J., Khalil, S., and Maurer, M.:Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria. J. Eur. Acad. Dermatol. Venereol. 2017: 31; 1715-1721. IF: 4.29

132	Weller, K., Viehmann, K., Bräutigam, M., Krause, K., Siebenhaar, F., Zuberbier, T., and Maurer, M.+: Cost-intensive, time-consuming, problematical? – How physicians in private practice experience the care of urticaria patients. J. Dtsch. Dermatol. Ges. 2012: 10; 341-347. IF: 1.40

146	Maurer, M.+ Aberer, W., Bouillet, L., Caballero, T., Fabien, V., Kanny, G., Kaplan, A., Longhurst, H., and Zanichelli, A.: Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS ONE 2013: 8; e53773. IF: 3.53

o.146

228	Gericke, J., Ohanyan, T., Church, M. K., Maurer, M.+ and Metz, M.: Omalizumab may not inhibit mast cell and basophil activation in vitro. J. Eur. Acad. Dermatol. Venereol. 2015: 29; 1832-1836. IF: 2.82

201	Hawro, T., Saluja, R., Weller, K., Altrichter, S., Metz, M., and Maurer, M.+: Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge. Allergy 2014: 69; 113-117. IF: 6.03

o.201

144	Konstantinou, G. N., Asero, R., Ferrer, M., Knol, E. F., Maurer, M. Raap, U., Schmid-Grendelmeier, P., Skol, P. S., and Grattan, C. E. H.+: EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013: 68; 27-36. IF: 5.99

271	Krause, K., Tsianakas, A., Wagner, N., Fischer, J., Weller, K., Metz, M., Church, M. K., and Maurer, M.:Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study. J. Allergy Clin. Immunol. 2017: 139; 1311-1320. IF: 13.26

186	Altrichter, S., Salow, J., Ardelean, E., Church, M. K.+, Werner, A., and Maurer, M.: Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. J. Dermatol. Sci. 2014: 75; 88-93. IF: 3.42

o.186

Results

Search Results for: Quiz 2024 EMC D-PDM-DY-23: Dell PowerProtect Data Manager Deploy 2023 Exam Updated Vce Download 🌋 Copy URL ➥ www.pdfvce.com 🡄 open and search for ⇛ D-PDM-DY-23 ⇚ to download for free 🥇Latest D-PDM-DY-23 Test Testking – Page 14

Monitoring recurrent angioedema: findings from the Turkish angioedea control test validation study

Urticaria: Current Opinions about Etiology, Diagnosis and Therapy

Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria

Cost-intensive, time-consuming, problematical? – How physicians in private practice experience the care of urticaria patients

Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment

Omalizumab may not inhibit mast cell and basophil activation in vitro

Interleukin-31 does not induce immediate itch in atopicdermatitis patients and healthy controls after skinchallenge

EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria

Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study

Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria